You are here

  • Home
  • Archive
  • Volume 30, Issue 1
  • A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc s…

Article metrics

Article menu
Download PDFPDF
Clinical trial
A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030)

 

Online download statistics by month:

Online download statistics by month: October 2019 to April 2024

AbstractFullPdf
Oct 20193241710
Nov 20196624526
Dec 20192864014
Jan 20207934429
Feb 20203182812
Mar 20202532014
Apr 202020984
May 20202761711
Jun 2020182127
Jul 20202971111
Aug 202020663
Sep 202022993
Oct 202020587
Nov 202028877
Dec 2020208124
Jan 2021210114
Feb 202119177
Mar 2021240412
Apr 202124914
May 20211031214
Jun 20211368
Jul 20211147
Aug 20212158
Sep 2021822
Oct 202125774
Nov 202120863
Dec 2021253912
Jan 202222172
Feb 2022228107
Mar 202226887
Apr 2022294149
May 202225533
Jun 2022300109
Jul 202219373
Aug 202228512
Sep 202225897
Oct 2022310113
Nov 2022251114
Dec 202218832
Jan 2023240117
Feb 202326395
Mar 202330795
Apr 202330754
May 202327164
Jun 202326984
Jul 202326194
Aug 202327966
Sep 2023310114
Oct 2023389152
Nov 20234993012
Dec 2023479226
Jan 20242651211
Feb 20242881112
Mar 202430885
Apr 202425537
Total14541627403